Aarkstore - Traumatic Brain Injury Therapeutics

Page 1

AArkstore enterprise 1thDecember 2014

Traumatic Br ain Injury Ther apeutics Pipeline Assessment and Market Browse Full Report @ http://whttp://www.aarkstore.com/pharmaceuticals-healthcare/60369/traumatic-braininjury-therapeutics-pipeline-assessment-and-market-forecasts Published: Jun 2012 | No. Of Pages: 98 Pages PDF: $ 3995 | Site Licence : $ 7990 | Enterprise Wide Licence : $ 11985

Forecasts to 2019

Summary The industry analysis specialist, has released its new report, “Traumatic Brain Injury Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Traumatic Brain Injury Therapeutics market. The report identifies the key trends shaping and driving the global Traumatic Brain Injury Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Traumatic Brain Injury Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts

Website : http://www.aarkstore.com/


AArkstore enterprise Scope The report provides information on the key drivers and challenges of the Traumatic Brain Injury Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Traumatic Brain Injury Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Traumatic Brain Injury Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Traumatic Brain Injury Therapeutics market. - Analysis of key recent licensing and partnership agreements in Traumatic Brain Injury Therapeutics market

Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Traumatic Brain Injury Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Traumatic Brain Injury Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Website : http://www.aarkstore.com/


AArkstore enterprise - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Traumatic Brain Injury Therapeutics market landscape? – Identify, understand and capitalize.

Special Discount on Global Data Market Research Reports: Click here an avail Discount offer on Global Data market research reports: http://www.aarkstore.com/discount.php Discount Valid till 31st December 2014 For Research Reports Call us on: +91 9987295242 OR Mail us at contact@aarkstore.com

Tables Of Contents 2 Traumatic Brain Injury Therapeutics - Introduction 2.1 Disease Overview 2.1.1 Classification of Traumatic Brain Injury 2.1.2 Types of Traumatic Brain Injury 2.1.3 Effects of Traumatic Brain Injury

Website : http://www.aarkstore.com/


AArkstore enterprise 2.1.4 Post-Injury Complications Associated with Traumatic Brain Injury 2.2 Epidemiology 2.2.1 Traumatic Brain Injury: “A Silent Epidemic� in the US 2.2.2 The UK 2.2.3 Spain 2.2.4 France 2.2.5 Italy 2.2.6 Germany 2.2.7 Japan 2.2.8 Mortality 2.2.9 Quality of Life Parameters 2.2.10 Pharmacoeconomic Burden 2.3 Etiology 2.4 Pathophysiology 2.4.1 Primary Injury 2.4.2 Secondary Injury 2.4.3 Inflammatory Response 2.4.4 Repair-Regeneration 2.5 Signs and Symptoms 2.6 Diagnosis 2.6.1 Initial Measures 2.6.2 Complete Clinical Evaluation 2.7 Treatment and Management Pattern

Website : http://www.aarkstore.com/


AArkstore enterprise 2.7.1 Acute Management of Traumatic Brain Injury in Hospital 2.7.2 Treatment of Mild Traumatic Brain Injury 2.7.3 Treatment of Post-Traumatic Brain Injury Complications 2.7.4 Rehabilitation 2.8 Referral Pathway 2.9 GlobalData Pipeline Report Guidance 3 Traumatic Brain Injury Therapeuctics - Market Characterization 3.1 Overview 3.2 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – Global 3.3 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – Global 3.4 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury – Global 3.5 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – The US 3.6 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – The US 3.7 Traumatic Brain Injury Therapeutics Market Distribution based on Severity of Injury – The US 3.8 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – France 3.9 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – France 3.10 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, France 3.11 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – Germany 3.12 Traumatic Brain Injury Therapeutics Market Forecast (2011-2019) – Germany 3.13 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, Germany 3.14 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – Italy 3.15 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – Italy 3.16 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, Italy

Website : http://www.aarkstore.com/


AArkstore enterprise 3.17 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – Spain 3.18 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – Spain 3.19 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, Spain 3.20 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – The UK 3.21 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – The UK 3.22 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, The UK 3.23 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – Japan 3.24 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – Japan 3.25 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, Japan 3.26 Drivers and Barriers for Traumatic Brain Injury Therapeutics Market 3.26.1 Drivers for Traumatic Brain Injury Therapeutics Market 3.26.2 Barriers for TBI Therapeutics Market 3.27 Opportunity and Unmet Need Analysis 3.27.1 Opportunity and Unmet Need in Traumatic Brain Injury Therapeutics Market 3.28 Key Takeaway 4 Traumatic Brain Injury Therapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profile for the Major Product in the Traumatic Brain Injury Therapeutics 4.3.1 Mannitol 4.4 Key Takeaway 5 Traumatic Brain Injury Therapeutics - Pipeline Assessment 5.1 Overview

Website : http://www.aarkstore.com/


AArkstore enterprise 5.2 Strategic Pipeline Assessment 5.3 Traumatic Brain Injury Therapeutics Pipeline – Pipeline by Phases of Development 5.3.1 Traumatic Brain Injury Therapeutics – Phase III Pipeline 5.3.2 Traumatic Brain Injury Therapeutics –Phase II Pipeline 5.3.3 Traumatic Brain Injury Therapeutics – Phase I/II Pipeline 5.3.4 Traumatic Brain Injury Therapeutics –Phase I Pipeline 5.3.5 Traumatic Brain Injury Therapeutics – IND Filed 5.3.6 Traumatic Brain Injury Therapeutics – Preclinical Phase 5.3.7 Traumatic Brain Injury Therapeutics – Discovery Pipeline 5.4 Technology Trends Analytic Framework 5.5 Traumatic Brain Injury Therapeutics Market –Pipeline by Mechanism of Action 5.6 Molecule Profiling for Promising Drug under Clinical development 5.6.1 BHR-100 5.7 Key Takeaway 6 Traumatic Brain Injury Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region/ Country 6.2 Clinical Trials by Phase 6.3 Clinical Trials by Trial Status 6.4 Top 10 companies participating in Therapeutics Clinical Trials 6.5 Prominent Sponsors 7 Traumatic Brain Injury Therapeutics - Strategic Assessment 7.1 Key Events Impacting the Future Traumatic Brain Injury Market 7.2 Implications for Future Traumatic Brain Injury Market Competition

Website : http://www.aarkstore.com/


AArkstore enterprise 8 Traumatic Brain Injury Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 BHR Pharma, LLC 9 Traumatic Brain Injury Therapeutics - Appendix 9.1 Market Definitions 9.2 Abbreviations 9.3 Bibliography 9.4 Research Methodology 9.4.1 Coverage 9.4.2 Secondary Research 9.4.3 Primary Research 9.4.4 Modelling and Forecasting 9.4.5 Expert Panel Validation 9.5 Contact Us 9.6 Disclaimer

List Of Tables Table 1: Glasgow Coma Scale Table 2: Clinical Severity (Injury Severity Score) Table 3: Severity of Brain Injury Table 4: Structural Damage (CT) Table 5: Types of Traumatic Brain Injury

Website : http://www.aarkstore.com/


AArkstore enterprise Table 6: Immediate Post-Injury Complications Table 7: Long-Term Complications Associated with Traumatic Brain Injury Table 8: Incidence Pool of Traumatic Brain Injury Patients in Seven Major Markets Table 9: Rates of Disability in the General Population of the US Table 10: Key Opinion Leader Insights, Mortality Rate of Traumatic Brain Injury in the US, the UK and Japan Table 11: Symptoms of Traumatic Brain Injury Table 12: Frequency of Mild Traumatic Brain Injury Symptoms in General Population and in Traumatic Brain Injury Patients Table 13: Severity Assessment of Traumatic Brain Injury based on GCS Table 14: Key Opinion Leader Insights, Diagnosis Rate of Traumatic Brain Injury in the US, the UK and Japan Table 15: Key Opinion Leader Insights, Percentage of Traumatic Brain Injury Patients Develop Complications Table 16: Key Opinion Leader Insights, Geographical Differences in Treatment and Management Pattern of Medical Complications of Traumatic Brain Injury, 2012 Table 17: Treatment and Management of Headache (Includes Tension and Migraine) Table 18: Treatment and Management of Dizziness and Disequilibrium Table 19: Treatment and Management of Fatigue and Sleep Disturbances Table 20: Treatment and Management of Vision, Hearing, Olfactory Symptoms Table 21: Treatment and Management of Irritability Table 22: Treatment and Management of Appetite Changes and Nausea Table 23: Management of Traumatic Brain Injury Sequelaes with Pharmacological Agents Table 24: Traumatic Brain Injury Therapeutics Market, Global, Market Size, ($m), 2006–2011 Table 25: Traumatic Brain Injury Therapeutics Market, Global, Forecast ($m), 2011–2019 Table 26: Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, Global Table 27: Traumatic Brain Injury Therapeutics Market, The US, Market Size, ($m), 2006–2011

Website : http://www.aarkstore.com/


AArkstore enterprise Table 28: Traumatic Brain Injury Therapeutics Market, The US, Forecast ($m), 2011–2019 Table 29: Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of TBI, The US Table 30: Traumatic Brain Injury Therapeutics Market, France, Market Size, ($m), 2006–2011 Table 31: Traumatic Brain Injury Therapeutics Market, France, Forecast ($m), 2011–2019 Table 32: Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, France Table 33: Traumatic Brain Injury Therapeutics Market, Germany, Market Size, ($m), 2006–2011 Table 34: Traumatic Brain Injury Therapeutics Market, Germany, Forecast ($m), 2011–2019 Table 35: Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, Germany Table 36: Traumatic Brain Injury Therapeutics Market, Italy, Market Size, ($m), 2006–2011 Table 37: Traumatic Brain Injury Therapeutics Market, Italy, Forecast ($m), 2011–2019 Table 38: Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, Italy Table 39: Traumatic Brain Injury Therapeutics Market, Spain, Market Size, ($m), 2006–2011 Table 40: Traumatic Brain Injury Therapeutics Market, Spain, Forecast ($m), 2011–2019 Table 41: Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of TBI, Spain Table 42: Traumatic Brain Injury Therapeutics Market, The UK, Market Size, ($m), 2006–2011 Table 43: Traumatic Brain Injury Therapeutics Market, The UK, Forecast ($m), 2011–2019 Table 44: Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, The UK Table 45: Traumatic Brain Injury Therapeutics Market, Japan, Market Size, ($m), 2006–2011 Table 46: Traumatic Brain Injury Therapeutics Market, Japan, Forecast ($m), 2011–2019 Table 47: Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, The UK Table 48: Traumatic Brain Injury Therapeutics – Phase III Clinical Pipeline, 2012 Table 49: Traumatic Brain Injury Therapeutics – Phase II Clinical Pipeline, 2012 Table 50: Traumatic Brain Injury Therapeutics – Phase I/II Clinical Pipeline, 2012

Website : http://www.aarkstore.com/


AArkstore enterprise Table 51: Traumatic Brain Injury Therapeutics – Phase I Clinical Pipeline, 2011 Table 52: Traumatic Brain Injury Therapeutics – IND Filed, 2012 Table 53: Traumatic Brain Injury Therapeutics –Preclinical Pipeline, 2012 Table 54: Traumatic Brain Injury Therapeutics – Discovery Pipeline, 2012 Table 55: Traumatic Brain Injury Therapeutics Market, Clinical Trials by Region/ Country, 2012 Table 56: Traumatic Brain Injury Therapeutics Market, Clinical Trials by Phase, 2012 Table 57: Traumatic Brain Injury Therapeutics Market, Clinical Trials by Trial Status, 2012 Table 58: Traumatic Brain Injury Therapeutics Market, Clinical Trials by Top Companies Participating in Traumatic Brain Injury Therapeutics Clinical Trials, 2012 Table 59: Traumatic Brain Injury Therapeutics Market – Clinical Trials by Overall Sponsors, 2012 Table 60: Traumatic Brain Injury Therapeutics Market – Clinical Trials by Prominent Sponsors, 2012 Table 61: BHR Pharma – Central Nervous System Pipeline Products, 2011

List Of Figures Figure 1: Effects of Traumatic Brain Injury Figure 2: Key Opinion Leader Insights, Incidence Trend of Traumatic Brain Injury in the US, the UK and Japan Figure 3: Comparison of Annual Incidence of Traumatic Brain Injury with Other Diseases Figure 4: Average Annual Rates for Traumatic Brain Injury Deaths, by Age Group and Sex- The US, 1997-2007 Figure 5: Causes of Traumatic Brain Injury Figure 6: Processes in Traumatic Brain Injury Figure 7: Various Pathological Findings Detected in CT Scan in Traumatic Brain Injury Patients Figure 8: Diagnostic Approaches in Traumatic Brain Injury Figure 9: Post-Traumatic Brain Injury Medical Complications Figure 10: Treatment Continuum of Traumatic Brain Injury

Website : http://www.aarkstore.com/


AArkstore enterprise Figure 11: Key Opinion Leader Insights, Referral Pathway of Traumatic Brain Injury in the US, the UK and Japan Figure 12: Traumatic Brain Injury Therapeutics Market, Global, Market Size ($m), 2006–2011 Figure 13: Traumatic Brain Injury Therapeutics Market, Global, Forecast ($m), 2011–2019 Figure 14: Traumatic Brain Injury Therapeutics Market, The US, Market Size ($m), 2006–2011 Figure 15: Traumatic Brain Injury Therapeutics Market, The US, Forecast ($m), 2011–2019 Figure 16: Traumatic Brain Injury Therapeutics Market, France, Market Size ($m), 2006–2011 Figure 17: Traumatic Brain Injury Therapeutics Market, France, Forecast ($m), 2011–2019 Figure 18: Traumatic Brain Injury Therapeutics Market, Germany, Market Size ($m), 2006–2011 Figure 19: Traumatic Brain Injury Therapeutics Market, Germany, Forecast ($m), 2011–2019 Figure 20: Traumatic Brain Injury Therapeutics Market, Italy, Market Size ($m), 2006–2011 Figure 21: Traumatic Brain Injury Therapeutics Market, Italy, Forecast ($m), 2011–2019 Figure 22: Traumatic Brain Injury Therapeutics Market, Spain, Market Size ($m), 2006–2011 Figure 23: Traumatic Brain Injury Therapeutics Market, Spain, Forecast ($m), 2011–2019 Figure 24: Traumatic Brain Injury Therapeutics Market, The UK, Market Size ($m), 2006–2011 Figure 25: Traumatic Brain Injury Therapeutics Market, The UK, Forecast ($m), 2011–2019 Figure 26: Traumatic Brain Injury Therapeutics Market, Japan, Market Size ($m), 2006–2011 Figure 27: Traumatic Brain Injury Therapeutics Market, Japan, Forecast ($m), 2011–2019 Figure 28: Projected Growth in Road Traffic Fatalities, 2002–2020: A Comparison of World Bank Projections with Global Burden of Disease Projections Figure 29: Key Opinion Leader Insights, Unmet Need in Traumatic Brain Injury Therapeutics Market Figure 30: Traumatic Brain Injury Therapeutics Pipeline by Phase of Development, 2012 Figure 31: Technology Trends Analytic Framework of the Traumatic Brain Injury Therapeutics Pipeline, 2012 Figure 32: Technology Trends Analytic Framework of the Traumatic Brain Injury Therapeutics Pipeline- Description, 2012

Website : http://www.aarkstore.com/


AArkstore enterprise Figure 33: Traumatic Brain Injury Therapeutics, Pipeline by Mechanism of Action, 2011 Figure 34: Traumatic Brain Injury Therapeutics Market – Clinical Trials by Region/Country, 2012 Figure 35: Traumatic Brain Injury Therapeutics Market – Clinical Pipeline by Phase, 2012 Figure 36: Traumatic Brain Injury Therapeutics Market – Clinical Trials by Trial Status, 2012 Figure 37: Traumatic Brain Injury Therapeutics Market, Clinical Trials by Top Companies Participating in Traumatic Brain Injury Therapeutics Clinical Trials, 2012 Figure 38: Traumatic Brain Injury Therapeutics Market – Clinical Trials by Overall Sponsors, 2012 Figure 39: Traumatic Brain Injury Therapeutics Market – Clinical Trials by Prominent Sponsors, 2012 Figure 40: Traumatic Brain Injury Therapeutics Market, Drivers and Barriers, 2012 Figure 41: Implications for Future Market Competition in the Traumatic Brain Injury Therapeutics Market, 2011 Figure 42: GlobalData Market Size Estimation Figure 43: GlobalData Market Forecasting Model

Discount reports: Amnesia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Posttraumatic Stress Disorder Therapeutics (PTSD) - Pipeline Assessment and Market Forecasts to 2019 Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Traumatic Brain Injury Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018

Website : http://www.aarkstore.com/


AArkstore enterprise About Aarkstore Enterprise Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.

You can order full Report with TOC and Sample page visit: http://www.aarkstore.com/pharmaceuticals-healthcare/60369/traumatic-braininjury-therapeutics-pipeline-assessment-and-market-forecasts

Contact Details: Aarkstore Enterprise Phone: +91 998 729 5242 Email: enquiry@aarkstore.com Our Website: http://www.aarkstore.com Facebook: https://www.facebook.com/aarkstoredotcom Linkedin: http://www.linkedin.com/company/aarkstore-enterprise

Website : http://www.aarkstore.com/


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.